Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
10/19/2000 | CA2370131A1 62 human secreted proteins |
10/19/2000 | CA2370114A1 Method for obtaining a. niger cultures and their uses for producing ferulic acid and vanillic acid |
10/19/2000 | CA2370112A1 Uncoupling proteins |
10/19/2000 | CA2369974A1 Plant activator, process for producing the same, activation method, activity promoter and method for applying the promoter |
10/19/2000 | CA2369822A1 Novel human voltage-gated potassium channel |
10/19/2000 | CA2369619A1 Caspase inhibitors and the use thereof |
10/19/2000 | CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer |
10/19/2000 | CA2369413A1 Transmembrane protein expressed in prostate and other cancers |
10/19/2000 | CA2366520A1 Anti-bacterial vaccine compositions |
10/19/2000 | CA2366359A1 Novel essential bacterial genes and their proteins |
10/19/2000 | CA2365919A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents |
10/19/2000 | CA2365918A1 49 human secreted proteins |
10/19/2000 | CA2365917A1 Bone morphogenic proteins |
10/19/2000 | CA2365916A1 Novel lipoxygenase proteins and polynucleotides encoding the same |
10/19/2000 | CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
10/19/2000 | CA2365914A1 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
10/19/2000 | CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same |
10/19/2000 | CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
10/19/2000 | CA2365910A1 Human proteins and polynucleotides encoding them |
10/19/2000 | CA2365905A1 48 human secreted proteins |
10/19/2000 | CA2365623A1 Tyrosine kinase substrate (tks) proteins |
10/19/2000 | CA2365522A1 48 human secreted proteins |
10/19/2000 | CA2364565A1 Glucose dehydrogenases |
10/19/2000 | CA2364558A1 Process for the production of yeast biomass comprising functionally deleted hxk2 genes |
10/19/2000 | CA2364541A1 Genes associated with diseases of the kidney |
10/18/2000 | EP1045029A2 Process for producing optically active 4-hydroxy-2-ketoglutaric acids |
10/18/2000 | EP1045028A1 Deoxyribonucleases |
10/18/2000 | EP1044988A1 Process for steeping corn and steepwater having a low reducing sugar content made therefrom |
10/18/2000 | EP1044685A2 Farnesol derivatives for morphological transition control over dimorphic fungi |
10/18/2000 | EP1044277A2 Recombinant, active caspases and uses thereof |
10/18/2000 | EP1044276A2 Proteases from gram positive organisms |
10/18/2000 | EP1044275A1 Mammalian matrix-type metalloprotease |
10/18/2000 | EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE |
10/18/2000 | EP1044271A1 Il-1 delta dna and polypeptides |
10/18/2000 | EP1044270A2 Apoptosis inducing molecule ii |
10/18/2000 | EP1044269A1 Human vps35/mem3-related protein |
10/18/2000 | EP1044267A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
10/18/2000 | EP1044266A2 Human signal peptide-containing proteins |
10/18/2000 | EP1044264A2 Branched chain amino acid biosynthetic enzymes |
10/18/2000 | EP1044219A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5 |
10/18/2000 | EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto |
10/18/2000 | EP1044217A2 Sag: sensitive to apoptosis gene |
10/18/2000 | EP1044216A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1 |
10/18/2000 | EP1044212A1 Human fk506 binding proteins |
10/18/2000 | EP1044211A1 36 human secreted proteins |
10/18/2000 | EP1044210A1 Human dendriac and brainiac-3 |
10/18/2000 | EP1044009A2 Methods and compositions employing red rice fermentation products |
10/18/2000 | EP0577666B1 Polypeptides from mycobacterium paratuberculosis |
10/18/2000 | CN1270637A Isolation of a novel senescence-factor gene, P23 |
10/18/2000 | CN1270632A APPIL-a novel protein with growth effects |
10/18/2000 | CN1270631A Process for producing purine nucleosides via fermentation |
10/18/2000 | CN1270497A Toxin genes from the bacteria i (xenorhabdus nematophilus) and i (photorhabdus luminescens) |
10/18/2000 | CN1270227A Combined mycoplasma test reagent and preparing process thereof |
10/18/2000 | CN1270226A Production of L-glutamic acid by fermentation |
10/18/2000 | CN1270223A Method for producing L-argenine and synthesising emzyme gene by carbamyl phosphoric acid of corynebacterium |
10/18/2000 | CN1057568C Process for preparation of D-alpha-amino acids |
10/18/2000 | CN1057567C Colone and/or express vectors, process of production and use thereof |
10/18/2000 | CN1057564C Microbe capable of producing active recombinant phycabiliprotein and its preparing method |
10/18/2000 | CN1057563C Bacterial stain of bacillus subtilis and application thereof |
10/18/2000 | CN1057562C Method for making UK61,689 |
10/18/2000 | CN1057561C Method for regulating growth of microorgans |
10/18/2000 | CN1057535C Process for producing hydrophobic polypeptides proteins or peptides |
10/17/2000 | US6133421 Polypeptides and polypeptide subunits of a stereospecific nitrile hydratase enzyme |
10/17/2000 | US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
10/17/2000 | US6133030 Co-cultivation of cells in a micropatterned configuration |
10/17/2000 | US6133025 Nucleic acid for episomal replication in mammalian cells; includes a cis-acting origin of replication sequence and the nuclear antigen 1 sequence linked to a promoter; for gene therapy |
10/17/2000 | US6133023 Expression vector including a promoter region controlled by environmental factors such as ph, growth temperature, oxygen content, and others and at least one restriction site; for increased gene expression/production of vaccines |
10/17/2000 | US6133021 Bioreactor system and method for probing toxic materials |
10/17/2000 | US6133017 Attenuated strain of Leishmania |
10/17/2000 | US6133016 Sphingomonas biodesulfurization catalyst |
10/17/2000 | US6133014 Maleate isomerase gene |
10/17/2000 | US6133007 Phosphodiesterase 8A |
10/17/2000 | US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections |
10/17/2000 | US6133005 Enzymatic protein; for the treatment of nervous system disorders associated with thamine vitamin deficiency |
10/17/2000 | US6133003 Process for the preparation of vanillin and microorganisms suitable therefor |
10/17/2000 | US6132999 Nucleotide sequences coding threonine operon; for the fermentation of threonine |
10/17/2000 | US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis |
10/17/2000 | US6132985 Methods for the detoxification of nitrile and/or amide compounds |
10/17/2000 | US6132983 Microorganismal protein with enzymatic activity associated with luminescence |
10/17/2000 | US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation |
10/17/2000 | US6132963 Nucleotide sequences coding modulator protein; for the detection of modulation of signal transduction |
10/17/2000 | US6132734 Cloning of mite allergens |
10/17/2000 | US6132713 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
10/17/2000 | CA2068320C Production of recombinant human interleukin-1 inhibitor |
10/17/2000 | CA1341123C Filamentous hemagglutinin of b. pertussis |
10/17/2000 | CA1341117C Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, dna fragments and recombinants for use in the production of said cells and plants |
10/14/2000 | CA2269043A1 Method for disposing food wastes at low and ordinary temperatures using microbes and apparatus therefor |
10/12/2000 | WO2000060120A2 Methods of detecting microorganism using immobilized probes |
10/12/2000 | WO2000060102A2 Bacterial fimbrial system for presentation of heterologous peptide sequences |
10/12/2000 | WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase |
10/12/2000 | WO2000060095A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
10/12/2000 | WO2000060094A1 Modified lactococci expressing a catalase and their uses |
10/12/2000 | WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection |
10/12/2000 | WO2000060087A2 Cyclin dependent kinase inhibitor genes from plants |
10/12/2000 | WO2000060082A2 Vesicle associated proteins |
10/12/2000 | WO2000060080A2 Molecules of the immune system |
10/12/2000 | WO2000060077A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
10/12/2000 | WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |